Announcement on Resolutions of the Sixth Meeting of the Third Board of Supervisors

release time:

2023-08-04 15:53

Stock code: 832316 Securities abbreviation: Tim Biotech Host brokerage: Shenwan Hongyuan underwriting sponsor

 

Jilin Tianzheng Biotechnology Co., Ltd
Announcement of the resolution of the sixth meeting of the third board of supervisors

 

The Company and all members of the Board of Supervisors guarantee that the content of the announcement is true, accurate and complete, and there are no false records, misleading statements or material omissions, and assume individual and joint responsibility for the authenticity, accuracy and completeness of the contentWith legal liability.

 

1. Convening and attendance at meetings
(1) The convening of the meeting
1. The meeting will be held on May 2023, 4
2. Meeting location: conference room on the third floor of the company
3. Meeting mode: on-site
4. Time and manner of notice of the meeting of the Supervisory Board: in writing on April 2023, 4
5. Moderator: Shi Chunyan, Chairman of the Board of Supervisors
6. Legal compliance description of the convening situation:
The convocation and holding of this meeting conforms to the relevant provisions of the Company Law and related laws, regulations and the Articles of Association.
(2) Attendance at the meeting
There shall be 3 supervisors present at the meeting, and 3 supervisors present and authorized to attend.

 

2. Deliberation of motions
(2022) Deliberate and adopt the motion on the > of the <> Annual Report of the Board of Supervisors of the Company <
1. Content of the motion:
2022 Annual Report of the Board of Supervisors.
2. Voting result of the motion: 3 votes in favor; 0 votes against; 0 abstentions.
3. Recusal from voting
Not.
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2022) Deliberate and adopt the "> on the Company's <> Annual Financial Final Report <"
1. Content of the motion:
Financial Report 2022.
2. Voting result of the motion: 3 votes in favor; 0 votes against; 0 abstentions.
3. Recusal from voting
Not.
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2023) Deliberate and adopt the "> on the Company's <<> Annual Financial Budget Plan"
1. Content of the motion:
2023 Financial Budget Proposal.
2. Voting result of the motion: 3 votes in favor; 0 votes against; 0 abstentions.
3. Recusal from voting
Not.
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2022) Deliberate and pass the "> on the Company's <<> Profit Distribution Plan"
1. Content of the motion:
In order to improve the soundness of finance, enhance the ability to resist risks, achieve sustainable, stable and healthy development of the company, and better safeguard the long-term interests of all shareholders, based on the actual situation of the company, the board of directors decided to:No profit distribution for 2022 will be made.
2. Voting result of the motion: 3 votes in favor; 0 votes against; 0 abstentions.
3. Recusal from voting
Not.
The proposal has yet to be submitted to the general meeting of shareholders for consideration.
(2022) Deliberate and adopt the "Summary > on the Company's < 2022 Annual Report and <> Annual Report"
1. Content of the motion:
According to the "Information Disclosure Rules for Companies Listed on the National Small and Medium-sized Enterprises Share Transfer System" and the "About Doing a Good Job in the Disclosure of the 2022 Annual Report of Listed Companies" issued by the National SME Share Transfer System Co., LtdNotice of Work", the Company's Supervisory Board reviewed the Company's 2022 Annual Reportand issued the following review opinions:
1. The preparation and deliberation procedures of the annual report comply with laws and regulations, the provisions of the China Securities Regulatory Commission, the National Small and Medium-sized Enterprise Stock Transfer System Co., Ltd., the articles of association, and the company's internal management system
Provisions;
2. The content and format of the annual report comply with the provisions of the Guidelines for the Content and Format of Information Disclosure of Unlisted Public Companies No. 9 - Annual Report of Companies Listed on the Innovation Layer, and no annual report of the company in 2022 has been foundThe information contained contains that does not correspond to the reality and the Company's 2022 Annual Report is a true reflection of the Companyresults of operations and financial condition for the year 2022;
3. Before the submission of this opinion, it was not found that the personnel involved in the preparation and review of the annual report had violated the confidentiality provisions.
In addition, all members of the board of supervisors also attended the 17th meeting of the third board of directors of the company as observers, and performed the duties of supervisors in accordance with the law.
2. Voting result of the motion: 3 votes in favor; 0 votes against; 0 abstentions.
3. Recusal from voting
Not.
The proposal has yet to be submitted to the general meeting of shareholders for consideration.

 

3. Catalog of documents for reference
"Resolution of the Sixth Meeting of the Third Board of Supervisors of Jilin Tianzheng Biotechnology Co., Ltd."
Written Audit Opinion of the Supervisory Board on the Annual Report 2022

 

Jilin Tianzheng Biotechnology Co., Ltd
Supervisory board
June 2023, 4